Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.33 EUR
44.60 M EUR
313.76 M EUR
69.03 M
About VITROLIFE AB
Sector
Industry
CEO
Bronwyn Brophy O'Connor
Website
Headquarters
Gothenburg
Founded
1989
ISIN
SE0011205202
FIGI
BBG000DPCYC8
Vitrolife AB develops, produces, and markets products for creating, prolonging, and improving life. It focuses on fertility treatments, cell therapy and tissue engineering, and organ transplantation systems. The company was founded in 1994 and is headquartered in Gothenburg, Sweden.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of VTFN is 18.28 EUR — it has decreased by −2.90% in the past 24 hours. Watch VITROLIFE AB SK 0,2 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange VITROLIFE AB SK 0,2 stocks are traded under the ticker VTFN.
VTFN stock has fallen by −2.00% compared to the previous week, the last month showed zero change in price, over the last year VITROLIFE AB SK 0,2 has showed a 6.46% increase.
We've gathered analysts' opinions on VITROLIFE AB SK 0,2 future price: according to them, VTFN price has a max estimate of 24.25 EUR and a min estimate of 22.95 EUR. Watch VTFN chart and read a more detailed VITROLIFE AB SK 0,2 stock forecast: see what analysts think of VITROLIFE AB SK 0,2 and suggest that you do with its stocks.
VTFN reached its all-time high on Nov 1, 2021 with the price of 57.25 EUR, and its all-time low was 10.41 EUR and was reached on Mar 24, 2020. View more price dynamics on VTFN chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
VTFN stock is 0.98% volatile and has beta coefficient of 0.13. Track VITROLIFE AB SK 0,2 stock price on the chart and check out the list of the most volatile stocks — is VITROLIFE AB SK 0,2 there?
Today VITROLIFE AB SK 0,2 has the market capitalization of 2.48 B, it has decreased by −2.90% over the last week.
Yes, you can track VITROLIFE AB SK 0,2 financials in yearly and quarterly reports right on TradingView.
VITROLIFE AB SK 0,2 is going to release the next earnings report on Apr 24, 2025. Keep track of upcoming events with our Earnings Calendar.
VTFN earnings for the last quarter are 0.09 EUR per share, whereas the estimation was 0.10 EUR resulting in a −6.87% surprise. The estimated earnings for the next quarter are 0.10 EUR per share. See more details about VITROLIFE AB SK 0,2 earnings.
VITROLIFE AB SK 0,2 revenue for the last quarter amounts to 83.37 M EUR, despite the estimated figure of 82.05 M EUR. In the next quarter, revenue is expected to reach 81.64 M EUR.
VTFN net income for the last quarter is 12.08 M EUR, while the quarter before that showed 10.21 M EUR of net income which accounts for 18.36% change. Track more VITROLIFE AB SK 0,2 financial stats to get the full picture.
Yes, VTFN dividends are paid annually. The last dividend per share was 0.09 EUR. As of today, Dividend Yield (TTM)% is 0.48%. Tracking VITROLIFE AB SK 0,2 dividends might help you take more informed decisions.
As of Feb 11, 2025, the company has 1.12 K employees. See our rating of the largest employees — is VITROLIFE AB SK 0,2 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. VITROLIFE AB SK 0,2 EBITDA is 108.32 M EUR, and current EBITDA margin is 34.14%. See more stats in VITROLIFE AB SK 0,2 financial statements.
Like other stocks, VTFN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VITROLIFE AB SK 0,2 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So VITROLIFE AB SK 0,2 technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating VITROLIFE AB SK 0,2 stock shows the sell signal. See more of VITROLIFE AB SK 0,2 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.